Ardelyx (NASDAQ:ARDX) Now Covered by Scotiabank
Research analysts at Scotiabank began coverage on shares of Ardelyx (NASDAQ:ARDX – Get Free Report) in a research report issued on Friday,Benzinga reports. The brokerage set a “sector outperform” rating and a $15.00 price target on the biopharmaceutical company’s stock. Scotiabank’s price objective would suggest a potential upside of 183.02% from the company’s current price. […]
Research analysts at Scotiabank began coverage on shares of Ardelyx (NASDAQ:ARDX – Get Free Report) in a research report issued on Friday,Benzinga reports. The brokerage set a “sector outperform” rating and a $15.00 price target on the biopharmaceutical company’s stock. Scotiabank’s price objective would suggest a potential upside of 183.02% from the company’s current price. […]
